Literature DB >> 30324346

Advances in Radiotherapy for Prostate Cancer Treatment.

Tarun K Podder1, Elisha T Fredman2, Rodney J Ellis2.   

Abstract

Major categories of radiotherapy (RT) for prostate cancer (CaP) treatment are: (1) external beam RT (EBRT), and (2) brachytherapy (BT). EBRT are performed using different techniques like three-dimensional conformal RT (3D-CRT), intensity modulated RT (IMRT), volumetric modulated arc therapy (VMAT), and stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated proton therapy (IMPT), etc., using a variety of radiation delivery machines, such as a linear accelerator (Linac), Cyberknife robotic system, Gamma knife, Tomotherapy and proton beam machine. The primary advantage of proton beam therapy is sparing of normal tissues and organ at risks (OARs) with comparable coverage of the tumor volume. MR-Linac is the latest addition in the image-guided RT. Robot-assisted brachytherapy is one of the latest technological innovations in the field. With the advancement of technology, radiation therapy for prostate cancer can be improved using high quality multimodal imaging, robot-assistance for brachytherapy as well as EBRT. This chapter presents the advances in radiation therapy for the treatment of prostate cancer.

Entities:  

Mesh:

Year:  2018        PMID: 30324346     DOI: 10.1007/978-3-319-99286-0_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  Dose-volume Histogram-based Predictors for Hematuria and Rectal Hemorrhage in Patients Receiving Radiotherapy After Radical Prostatectomy.

Authors:  Katsuyuki Shirai; Masato Suzuki; Keiko Akahane; Yuta Takahashi; Masahiro Kawahara; Erika Yamada; Masaru Wakatsuki; Kazunari Ogawa; Satrou Takahashi; Kyosuke Minato; Kohei Hamamoto; Kimitoshi Saito; Masashi Oshima; Tsuzumi Konishi; Yuhki Nakamura; Satoshi Washino; Tomoaki Miyagawa
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Pelvic Radiation Disease.

Authors:  Tarik Sammour; Arman A Kahokehr
Journal:  Clin Colon Rectal Surg       Date:  2022-02-12

3.  Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis.

Authors:  Sungmin Woo; Sangwon Han; Tae-Hyung Kim; Chong Hyun Suh; Antonio C Westphalen; Hedvig Hricak; Michael J Zelefsky; Hebert Alberto Vargas
Journal:  AJR Am J Roentgenol       Date:  2019-12-04       Impact factor: 3.959

4.  Investigation of Chromosome 1 Aberrations in the Lymphocytes of Prostate Cancer and Benign Prostatic Hyperplasia Patients by Fluorescence in situ Hybridization.

Authors:  Justyna Miszczyk; Mikołaj Przydacz; Michał Zembrzuski; Piotr L Chłosta
Journal:  Cancer Manag Res       Date:  2021-05-31       Impact factor: 3.989

5.  The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer.

Authors:  Maria Goulielmaki; Nikolaos Davanos; Paraskevi Kogionou; Panagiota Batsaki; Savvas Stokidis; Maria Adamaki; Eftychia Mosa; Evanthia Vasilakou; Charalambos Zambatis; Angelos D Gritzapis; Vassilios Zoumpourlis; Constantin N Baxevanis; Sotirios P Fortis
Journal:  Int J Oncol       Date:  2022-04-21       Impact factor: 5.884

Review 6.  Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review.

Authors:  Junko Takahashi; Shinsuke Nagasawa
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

7.  The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering.

Authors:  Seyed Masoud Rezaeijo; Bijan Hashemi; Bahram Mofid; Mohsen Bakhshandeh; Arash Mahdavi; Mohammad Saber Hashemi
Journal:  Radiat Oncol       Date:  2021-09-20       Impact factor: 3.481

8.  Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy.

Authors:  Song Xue; Andrei Gafita; Chao Dong; Yu Zhao; Giles Tetteh; Bjoern H Menze; Sibylle Ziegler; Wolfgang Weber; Ali Afshar-Oromieh; Axel Rominger; Matthias Eiber; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-30       Impact factor: 10.057

9.  Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer.

Authors:  Elgin Hoffmann; Frank Paulsen; Philipp Schaedle; Daniel Zips; Cihan Gani; Hans-Georg Rammensee; Cécile Gouttefangeas; Franziska Eckert
Journal:  Cancer Immunol Immunother       Date:  2021-07-16       Impact factor: 6.968

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.